BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250910T015427EDT-0491UcrDGW@132.216.98.100
DTSTAMP:20250910T055427Z
DESCRIPTION:Nisha Almeida\, PhD\n\nManager |\n	The Health Technology Assessm
 ent Unit (TAU) | MUHC\n	Adjunct Professor | Division of Clinical Epidemiolo
 gy | 黑料社\n\nWHERE: Hybrid | 2001 黑料社 College\, Rm 1140 | Zoom \n\nNo
 te: Dr. Almeida will be presenting in-person from 2001 黑料社 College\, Rm
  1140\n\nAbstract\n\nHealth technology assessment (HTA) is a multidiscipli
 nary process that evaluates the clinical\, economic\, social and ethical i
 mplications of adopting a novel health intervention (medical devices\, pro
 cedures\, medications\, programmes or policies). HTA typically considers t
 he effectiveness\, safety\, cost-effectiveness\, and acceptability of heal
 th interventions to inform health policy and decision-making\, based on th
 e best-available scientific evidence.\n\nThis talk will describe the role 
 of the MUHC鈥檚 Health Technology Assessment Unit (TAU)\, an advisory group 
 that formulates recommendations directed at the MUHC administration and he
 althcare professionals\, in facilitating decision-making about the integra
 tion of novel health interventions at the hospital. The talk will focus on
  the principal factors that inform healthcare decision-making at the hospi
 tal level\, with a particular emphasis on the role of costing and financia
 l data in decision-making.\n\nLearning Objectives\n\nAt the completion of 
 this talk\, attendees will be able to:\n\n\n	Define health technology asses
 sment (HTA)\;\n	Describe a hospital-based HTA unit鈥檚 role in healthcare dec
 ision-making\;\n	Describe the role of cost data in decision-making at the h
 ospital level.\n\n\nSpeaker Bio\n\nNisha Almeida leads The Health Technolo
 gy Assessment Unit (TAU) of the MUHC\, an advisory group that assists the 
 hospital administration and clinical teams in making evidence-based decisi
 ons on the adoption of novel health interventions. Her team of scientists 
 conducts evaluations of new health interventions and of existing practice 
 to support optimal resource allocation towards high value care. Nisha has 
 a PhD in Epidemiology and Biostatistics from 黑料社. She is als
 o an adjunct professor in the Division of Clinical Epidemiology at 黑料社 
 University.\n\n聽\n\n聽\n
DTSTART:20240129T210000Z
DTEND:20240129T220000Z
SUMMARY:From Data to Decisions: The role of Health Technology Assessment in
  Innovative Healthcare
URL:/epi-biostat-occh/channels/event/data-decisions-ro
 le-health-technology-assessment-innovative-healthcare-354314
END:VEVENT
END:VCALENDAR